Bergantini L - Search Results

1

Serum KL-6 levels in pulmonary Langerhans' cell histiocytosis.

d'Alessandro M, Bergantini L, Cameli P, Lanzarone N, Antonietta Mazzei M, Alonzi V, Sestini P, Bargagli E. d'Alessandro M, et al. Among authors: bergantini l. Eur J Clin Invest. 2020 Apr 20:e13242. doi: 10.1111/eci.13242. Online ahead of print. Eur J Clin Invest. 2020. PMID: 32307698

2

The pathogenetic mechanisms of cough in idiopathic pulmonary fibrosis.

Bargagli E, Di Masi M, Perruzza M, Vietri L, Bergantini L, Torricelli E, Biadene G, Fontana G, Lavorini F. Bargagli E, et al. Among authors: bergantini l. Intern Emerg Med. 2019 Jan;14(1):39-43. doi: 10.1007/s11739-018-1960-5. Epub 2018 Sep 29. Intern Emerg Med. 2019. PMID: 30269188 Review.

3

Evaluation of multiple-flows exhaled nitric oxide in idiopathic and non-idiopathic interstitial lung disease.

Cameli P, Bargagli E, Bergantini L, Refini RM, Pieroni M, Sestini P, Rottoli P. Cameli P, et al. Among authors: bergantini l. J Breath Res. 2019 Mar 27;13(2):026008. doi: 10.1088/1752-7163/ab0233. J Breath Res. 2019. PMID: 30690441

4

Serial KL-6 analysis in patients with idiopathic pulmonary fibrosis treated with nintedanib.

Bergantini L, Bargagli E, Cameli P, Cekorja B, Lanzarone N, Pianigiani L, Vietri L, Bennett D, Sestini P, Rottoli P. Bergantini L, et al. Respir Investig. 2019 May;57(3):290-291. doi: 10.1016/j.resinv.2019.02.001. Epub 2019 Feb 21. Respir Investig. 2019. PMID: 30799155 No abstract available.

5

Prognostic Biomarkers of Sarcoidosis: A Comparative Study of Serum Chitotriosidase, ACE, Lysozyme, and KL-6.

Bergantini L, Bianchi F, Cameli P, Mazzei MA, Fui A, Sestini P, Rottoli P, Bargagli E. Bergantini L, et al. Dis Markers. 2019 Mar 3;2019:8565423. doi: 10.1155/2019/8565423. eCollection 2019. Dis Markers. 2019. PMID: 30944672 Free PMC article.

6

Rituximab therapy in interstitial lung disease associated with rheumatoid arthritis.

Fui A, Bergantini L, Selvi E, Mazzei MA, Bennett D, Pieroni MG, Rottoli P, Bargagli E. Fui A, et al. Among authors: bergantini l. Intern Med J. 2020 Mar;50(3):330-336. doi: 10.1111/imj.14306. Intern Med J. 2020. PMID: 30963656

7

Serum amyloid A in patients with idiopathic pulmonary fibrosis.

Vietri L, Bennett D, Cameli P, Bergantini L, Cillis G, Sestini P, Bargagli E, Rottoli P. Vietri L, et al. Among authors: bergantini l. Respir Investig. 2019 Sep;57(5):430-434. doi: 10.1016/j.resinv.2019.03.010. Epub 2019 Apr 26. Respir Investig. 2019. PMID: 31031123

8

Alveolar concentration of nitric oxide as a prognostic biomarker in idiopathic pulmonary fibrosis.

Cameli P, Bergantini L, Salvini M, Refini RM, Pieroni M, Bargagli E, Sestini P. Cameli P, et al. Among authors: bergantini l. Nitric Oxide. 2019 Aug 1;89:41-45. doi: 10.1016/j.niox.2019.05.001. Epub 2019 May 2. Nitric Oxide. 2019. PMID: 31054949

9

Pleuroparenchymal fibroelastosis in patients affected by systemic sclerosis: What should the rheumatologist do?

Bargagli E, Mazzei MA, Orlandi M, Gentili F, Bellisai F, Frediani B, Bergantini L, Carobene L, Randone SB, Guiducci S, Cameli P, Bruni C, Cerinic MM. Bargagli E, et al. Among authors: bergantini l. Medicine (Baltimore). 2019 Jun;98(26):e16086. doi: 10.1097/MD.0000000000016086. Medicine (Baltimore). 2019. PMID: 31261523 Free PMC article.

10

Oxidant/Antioxidant Disequilibrium in Idiopathic Pulmonary Fibrosis Pathogenesis.

Cameli P, Carleo A, Bergantini L, Landi C, Prasse A, Bargagli E. Cameli P, et al. Among authors: bergantini l. Inflammation. 2020 Feb;43(1):1-7. doi: 10.1007/s10753-019-01059-1. Inflammation. 2020. PMID: 31297749 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

147 results

Search Page

Filters